维普中文期刊产品整合服务
15篇 您的检索式:作者名="Tatokoro"
    题名 作者 年代 出处 被引量
1Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Reort of three cases 显示文摘Tatokoro M Fujii Y Kawakami S 2008Int J Uol2008,15,9:1
2Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer- initiating cells显示文摘Tatokoro M Koga F Yoshida S 2011Int J Cancer2011,30,12:1
3Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells显示文摘Tatokoro M Koga F Yoshida S 2012Int J Cancer2012,131,4:1
4Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer initiating cells显示文摘TATOKORO M KOGA F YOSHIDA S 2011Int J Cancer2011,30,12:1
5Favorable response to combina- tion treatment of cimetidinc, cyclooxygenase-2 inhibitor and rcnin-an- giotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases显示文摘Tatokoro M Fujii Y Kawakami S 2008Int J Uro12008,15,9:1
6Favorable response to combination treatment of cimetidine,cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma:Report of three cases显示文摘Tatokoro M Fujii Y Kawakami S 0,,09:1
7Phase-II trial of combination treatment of interferon-α,cimetidine,cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma显示文摘Tatokoro M Fujii Y Kawakami S 0,,01:1
8Phase-Ⅱtrial of combina-tion treatment of interferon-alpha,cimetidine,cyclooxygenase-2inhibitor and renin-angiotensin-system inhibitor(I-CCA therapy)for advanced renal cell carcinoma显示文摘Tatokoro M Fujii Y Kawakami S 2011Cancer Sci2011,102,1:1
9Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer‐initiating cells显示文摘Manabu Tatokoro Fumitaka Koga Soichiro Yoshida Satoru Kawakami Yasuhisa Fujii Len Neckers Kazunori Kihara 2011Int J Cancer2011,,4:1
10Favorable response to combina- tion treatment of cimetidine,cyclooxygenase-2 inhibitor and renin-an- giotensin system inhibitor in metastatic renal cell carcinoma:Report of three cases显示文摘Tatokoro M Fujii Y Kawakami S 2008Int J Uro12008,15,9:1
11Phase-Ⅱ trial of combination treatment of interferon-cl, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma显示文摘Tatokoro M Fujii Y Kawakami S 2011Cancer Sci2011,102,1:1
12Preoperative Serum Testosterone Level as an Independent Predictor of Treatment Failure following Radical Prostatectomy <ce:link locator='eulogo1'/>显示文摘Shinya Yamamoto Junji Yonese Satoru Kawakami Yuhei Ohkubo Manabu Tatokoro Yoshinobu Komai Hideki Takeshita Yuichi Ishikawa Iwao Fukui 2007European Urology2007,,3:1
13Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells显示文摘Tatokoro M Koga F Yoshida S 2012IntJ Cancer2012,131,4:1
14Preliminary report of multimodal treatment with ifosfamide,5-fluorouracil,etoposide and cisplatin(IFEP chemotherapy)against metastatic adenocarcinoma of the urachus显示文摘Tatokoro M Kawakami S Yonese J 2008Int J Urol2008,15,:1
15Phase-Ⅱ trial of combination treatment of interferon-α,cimetidine,cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor(I-CCA therapy) for advanced renal cell carcinoma显示文摘Tatokoro M Fujii Y Kawakami S 2011Cancer Sci2011,102,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费